Ben Rigby is a biotech executive with over 20 years of experience at GSK, where he transitioned to lead operations in the gene therapy sector. As VP of Business Operations at Beacon Therapeutics, he has been instrumental in company acquisitions, integration, and fundraising. He holds a Masters in Medicinal Chemistry.
Ben is motivated by translating science into clinical data to improve patient outcomes, particularly for those with devastating blinding conditions. He also shows a keen interest in youth innovation, finding inspiration in the competence and creativity of young teams.
Unique fact: Ben co-led the setup of a new functional genomics department at GSK in partnership with Boston Consulting Group.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.